Login Register Cart 0
Generic placeholder image

Anti-Infective Agents

Editor-in-Chief

ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Isolation Frequency of Uropathogenic Strains and Search for ESBL Producing Enterobacteriaceae Isolated from Patients with UTI in Bechar (Algeria)

Author(s): Elhassan Benyagoub*, Miaad K. Alkhudhairy, S. Mohamed Benchaib, Abdelmadjid Zaalan, Youcef Mekhfi, Nasreddine Teyebi, Dalila Razni and Farah Bendada

Volume 19, Issue 3, 2021

Published on: 24 December, 2020

Page: [303 - 316] Pages: 14

DOI: 10.2174/2211352518999201224102209

Price: $65

Abstract

Background: The emergence of multidrug-resistant uropathogenic strains, mainly the global spread of extended-spectrum beta-lactamase (ESBL) genes accompanied both by the uncontrolled use of antibacterial agents and a considerable decrease in their activities, makes the monitoring of the resistance pattern one of the necessary means that could help the medical practitioners to choose the best treatment. For this purpose and during four months from March 1 to June 30 (2019), an experimental study has been carried out on urine specimens of 123 inpatients (IP) and outpatients (OP) at infectious disease service Boudjemaa TOURABI Public Hospital of Bechar (Algeria), aiming the detection of ESBL-producing Enterobacteriaceae uropathogenic strains.

Methods: Firstly, the antibiotic susceptibility testing has been carried out by using the disk diffusion method to determine not only the multidrug resistance patterns, but also the multiple antibiotic resistance MAR indexes of uropathogenic strains that were isolated from clinical IP and OP samples. Secondly, the ESBL detection was done using the following methods: synergy tests based on the synergy between a third-generation cephalosporin and clavulanate, double-disc synergy test (DDST) and phenotypic tests on a cloxacillin-containing agar.

Results: As a result, 56 patients had a urinary tract infection (UTI) in overall 123 patients; thus, a frequency of 45,52%. Through a UTI’s frequency of 64,7%, the female gender was the most affected. All age groups were affected by UTI, with a mean age of 38,47±19,97 years old. Knowing that UTIs’ patients aging from 16 to 49 years old were the most affected compared to other ages’ groups, with a frequency of 66,6 and 50% for female and male gender, respectively. The microbial strains represented by the bacteria group were predominant, i.e. (98,22%) followed by yeasts (1,78%), where Gramnegative bacilli showed (96,36%) of the uropathogenic agents, so (3,64%) were Gram-positive bacteria. The antibiotic resistance profile of isolated Enterobacteriaceae showed very high resistance rates for the species of Escherichia coli, Klebsiella spp, and Proteus spp to aminopenicillins, cephalosporins, and less against carbapenems and other drug groups. E. coli had presented the highest multidrug resistance followed by Klebsiella spp with a MAR index ranged from 0,53 to 0,82. Within this range, a total of 28 isolate (25 E. coli, 2 Klebsiella spp, and 1 Proteus mirabilis) had shown resistance against 9 to 14 out of the 17 tested antibiotics. The rate of ESBL-producing Enterobacteriaceae strains was 23,07 and 55,26% for inpatients and outpatients, respectively, where E. coli was the most important ESBL producers out of all isolated strains.

Conclusion: An alarming ESBLs rate for outpatients is usually higher among inpatients with UTI, who receive several classes of antibiotics. Such conditions should be considered as a major public health concern, and measures must be taken to establish the sources and drivers of this issue. Thus, the findings of this research push the health sector stakeholders as well as the scientific communities to act on reducing the transmission of the multidrug-resistant strains that threaten several classes of life-saving antibiotics.

Keywords: Uropathogenic strains, ESBL producing Enterobacteriaceae, multidrug-resistant, phenotypic detection, UTI, Bechar (Algeria).

Graphical Abstract

[1]
Benyagoub, E; Benyagoub, El-H; Berbaoui, H; Rahmani, C Benyoucef, l Identification and study of the emergence of antibiotic resistance of microorganisms responsible for urinary tract infections in Bechar (Algeria). ScienceLib ‘Editions Mersenne’, 2013, 5, 1-13.
[2]
Lobel, B. Treatment of cystitis in women. Presse Med., 1995, 24(32), 1527-1529.
[PMID: 8545360]
[3]
Tantry, B.A.; Rahiman, S. Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley. West Indian Med. J., 2012, 61(7), 703-707.
[http://dx.doi.org/10.7727/wimj.2011.013] [PMID: 23620968]
[4]
Muhammad, A.; Ali, N.; Ali, S.; Shuaib, S.L.; Afridi, I.Q.; Saeed, W.; Khan, M.J. Antibiotics resistance of extended spectrum beta lactamases uropathogenic Escherichia coli in Peshawar-Pakistan. Pure Appl. Biol., 2020, 9(3), 1840-1848.
[http://dx.doi.org/10.19045/bspab.2020.90196]
[5]
Karou, S.D.; Ilboudo, I.P.; Nadembega, W.M.; Ameyapoh, Y.; Ouermi, D.; Pignatelli, S.; Pietra, V.; Traore, A.S.; de Souza, C.; Simpore, J. Antibiotic resistance in urinary tract bacteria in Ouagadougou. Pak. J. Biol. Sci., 2009, 12(9), 712-716.
[http://dx.doi.org/10.3923/pjbs.2009.712.716] [PMID: 19634476]
[6]
Tille, M.P. Bailey & Scott’s diagnostic microbiology, 14th ed; Elsevier, 2018.
[7]
CLSI. Performance standards for antimicrobial disk susceptibility testing M100, 28th Edition; Wayne Pennsylvania 19087-USA., 2018.
[8]
Khan, ZA; Siddiqui, MF; Park, S Current and emerging methods of antibiotic susceptibility testing. Diagn, (Basel), 2019, 9(2)
[http://dx.doi.org/10.3390/diagnostics9020049]
[9]
Nyandjou, YMC.; Yakubu, SE.; Abdullahi, IO.; Machido, DA. Multidrug resistance patterns and multiple antibiotic resitance index of Salmonella species isolated from waste dumps in Zaria Metropolis, Nigeria. J Appl Environ Manage., 2019, 23(1), 41-46.
[http://dx.doi.org/10.4314/jasem.v23i1.6]
[10]
Alkhudhairy, M.K.; Saki, M.; Seyed-Mohammadi, S.; Jomehzadeh, N.; Khoshnood, S.; Moradzadeh, M.; Yazdansetad, S. Integron frequency of Escherichia coli strains from patients with urinary tract infection in Southwest of Iran. J. Acute Dis., 2019, 8(3), 113-117.
[http://dx.doi.org/10.4103/2221-6189.259110]
[11]
Ayandele, A.A.; Oladipo, E.K.; Oyebisi, O.; Kaka, M.O. Prevalence of multi-antibiotic resistant Escherichia coli and Klebsiella species obtained from a tertiary medical institution in Oyo state, Nigeria. Qatar Med. J., 2020, 2020(1), 9.
[http://dx.doi.org/10.5339/qmj.2020.9] [PMID: 32280610]
[12]
Drieux, L.; Brossier, F.; Sougakoff, W.; Jarlier, V. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect., 2008, 14(1)(Suppl. 1), 90-103.
[http://dx.doi.org/10.1111/j.1469-0691.2007.01846.x] [PMID: 18154532]
[13]
Loukid, M.; Hilali, MK.; Bernis, C. Âge à la ménopause naturelle à Marrakech (Maroc) et prévalence des symptômes du climatère. Bull. Mem. Soc. Anthropol. Paris, 2007, 19(1-2), 65-75.
[14]
Benyagoub, E.; Benchaib, S.M.; Zaalan, A.; Bendada, F. Prevalence and isolation frequency of pathogenic strains responsible for some infections in Bechar’s community (Southwest of Algeria): About 1458 cases. Bangladesh J Med Sci., 2020, 19(3), 404-413.
[http://dx.doi.org/10.3329/bjms.v19i3.45856]
[15]
Coulibaly, S.D.B. Profil clinique et bactériologique de l’infection urinaire dans le service de néphrologie et d’hémodialyse du CHU du Point G., Thèse de Doctorat en médecine. Université de Bamako, Mali. 2010.
[16]
Zomahoun, T.J. Evaluation de la sensibilité aux antibiotiques des bactéries isolées des infections urinaires au laboratoire de bactériologie du centre national hospitalier universitaire-Hubert Koutoukou Maga (C.N.H.U.H.K.M.)., Thèse de Doctorat d’état, Université de Mali. 2005.
[17]
Sultana, M; Sultana, KF.; Mukharje, SK.; Parvez, MAK. Hossain, MA Characterization of Extended Spectrum β-Lactamase producing bacteria isolated from urinary tract infections. Bangladesh Med. Res. Counc. Bull., 2019, 45(1), 23-33.
[http://dx.doi.org/10.3329/bmrcb.v45i1.41805]
[18]
Talibi, Y. Infections urinaires à l'hôpital Ibn Sina., Thèse de Doctorat en Pharmacie, Faculté de médecine et pharmacie de Rabat, Université Mohammed V. 2008.
[19]
August, S.L.; De Rosa, M.J. Evaluation of the prevalence of urinary tract infection in rural Panamanian women. PLoS One, 2012, 7(10), e47752.
[http://dx.doi.org/10.1371/journal.pone.0047752] [PMID: 23094080]
[20]
Honnaville, C-E Analyse des facteurs prédictifs de récidive des prostatites aigues bactériennes communautaires au sein d’une cohorte prospective de 158 patients prise en charge en ambulatoire par un réseau de sante.., Thèse de Doctorat en médecine. Université Paris Diderot-Paris. France. 2014.
[21]
Baba Ahmed-Kazi Tani, Z.; Decré, D.; Genel, N.; Boucherit-Otmani, Z.; Arlet, G.; Drissi, M. Molecular and epidemiological characterization of enterobacterial multidrug-resistant strains in Tlemcen Hospital (Algeria) (2008-2010). Microb. Drug Resist., 2013, 19(3), 185-190.
[http://dx.doi.org/10.1089/mdr.2012.0161] [PMID: 23301522]
[22]
Al Wutayd, O.; Al Nafeesah, A.; Adam, I.; Babikir, I. The antibiotic susceptibility patterns of uropathogens isolated in Qassim, Saudi Arabia. J infect Dev Ctries., 2018, 12(11), 946-952.
[23]
Al-Khikani, FHO.; Kadim, BJ.; Ayit, AS.; Abidalali, MH. Evaluation cephalosporins resistance in pathogenic bacteria isolated clinically. World News Nat Sci., 2020, 31, 110-119.
[24]
Abayomi, S.A.; Adegboro, B.; Taiwo, S.S. Laboratory survey of extended spectrum beta-lactamase producing enterobacteriaceae in clinical infections among hospitalised patients at LAUTECH Teaching Hospital, Ogbomoso, Nigeria. Afr. J. Clin. Exp. Microbiol., 2020, 21(1), 66-71.
[http://dx.doi.org/10.4314/ajcem.v21i1.9]
[25]
APS. L’Algérie engagée dans la lutte contre la résistance aux antimicrobiens. Algérie Presse Service, Catégorie; Santé-Science- Technologie., 2018.http://www.aps.dz/sante-science-technologie/ 80609-l-algerie-engagee-pour-un-plan-de-lutte-contre-laresistance- aux-antimicrobiens
[26]
Gupta, K.; Hooton, T.M.; Naber, K.G.; Wullt, B.; Colgan, R.; Miller, L.G.; Soper, D.E. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis., 2011, 52(5), 103-120.
[27]
Livermore, D.M.; Pearson, A. Antibiotic resistance: location, location, location. Clin. Microbiol. Infect., 2007, 13(2)(Suppl. 2), 7-16.
[http://dx.doi.org/10.1111/j.1469-0691.2007.01724.x] [PMID: 17488371]
[28]
Magliano, E.; Grazioli, V.; Deflorio, L.; Leuci, A.I.; Mattina, R.; Romano, P.; Cocuzza, C.E. Gender and age-dependent etiology of community-acquired urinary tract infections. ScientificWorldJournal, 2012, 2012, 349597.
[http://dx.doi.org/10.1100/2012/349597] [PMID: 22629135]
[29]
Nedjai, S.; Barguigua, A.; Djahmi, N.; Jamali, L.; Zerouali, K.; Dekhil, M.; Timinouni, M. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria. Med. Mal. Infect., 2012, 42(1), 20-29.
[http://dx.doi.org/10.1016/j.medmal.2011.10.001] [PMID: 22056377]
[30]
Lagha, N. Etude de la résistance aux antibiotiques des entérobactéries productrices de β -lactamases à spectre étendu (BLSE) isolées de l’hôpital de Laghouat; Thèse de Doctorat, Faculté SNV, Département de Biologie, Université Abou Bekr Belkaid Tlemcen (Algérie).. , 2015.
[31]
Luvsansharav, U.O.; Hirai, I.; Niki, M.; Nakata, A.; Yoshinaga, A.; Moriyama, T.; Yamamoto, Y. Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J. Infect. Chemother., 2011, 17(5), 722-725.
[http://dx.doi.org/10.1007/s10156-011-0225-2] [PMID: 21359543]
[32]
Rodriguez-Villalobos, H.; Bogaerts, P.; Berhin, C.; Bauraing, C.; Deplano, A.; Montesinos, I.; de Mendonça, R.; Jans, B.; Glupczynski, Y. Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J. Antimicrob. Chemother., 2011, 66(1), 37-47.
[http://dx.doi.org/10.1093/jac/dkq388] [PMID: 21036771]
[33]
Elsayed, T.I.; Ismail, H.A.; Elgamal, S.A.; Gad Ahmed, H.A. The occurrence of multidrug resistant E. coli which produce ESBL and cause urinary tract infections. J. Appl. Microbiol. Biochem., 2017, 1(2), 2576-1412.
[http://dx.doi.org/10.21767/2576-1412.100008]
[34]
Severin, J.A.; Mertaniasih, N.M.; Kuntaman, K.; Lestari, E.S.; Purwanta, M.; Lemmens-Den Toom, N.; Duerink, D.O.; Hadi, U.; van Belkum, A.; Verbrugh, H.A.; Goessens, W.H. Study Group ‘Antimicrobial Resistance in Indonesia: Prevalence and Prevention’ (AMRIN). Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J. Antimicrob. Chemother., 2010, 65(3), 465-469.
[http://dx.doi.org/10.1093/jac/dkp471] [PMID: 20053690]
[35]
Abdelraheem, W.M. Fresh garlic extract has a synergistic effect with antibiotics on ESBLs producing E. coli urinary isolates. J. Adv. Microbiol., 2019, 1-9.
[36]
Villegas, M.V.; Kattan, J.N.; Quinteros, M.G.; Casellas, J.M. Prevalence of extended-spectrum β-lactamases in South America. Clin. Microbiol. Infect., 2008, 14(1)(Suppl. 1), 154-158.
[http://dx.doi.org/10.1111/j.1469-0691.2007.01869.x] [PMID: 18154539]
[37]
Al-Agamy, M.H.; Shibl, A.M.; Tawfik, A.F. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann. Saudi Med., 2009, 29(4), 253-257.
[http://dx.doi.org/10.4103/0256-4947.55306] [PMID: 19587523]
[38]
Feizabadi, M.M.; Mahamadi-Yeganeh, S.; Mirsalehian, A.; Mirafshar, S.M.; Mahboobi, M.; Nili, F.; Yadegarinia, D. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J. Infect. Dev. Ctries., 2010, 4(10), 609-615.
[http://dx.doi.org/10.3855/jidc.1059] [PMID: 21045352]
[39]
Wei, J.; Zou, C.; Wang, D.; Huang, A.; Niu, S. Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study. J. Glob. Antimicrob. Resist., 2020, 22, 448-451.
[http://dx.doi.org/10.1016/j.jgar.2020.04.023] [PMID: 32387260]
[40]
Briand, YM. Une histoire de la résistance aux antibiotiques A propos de six bactéries; Harmattan, Ed, Ed.; SCIENCES & TECHNIQUES France, 2009.
[41]
Rubin, M.A.; Samore, M.H. Antimicrobial use and resistance. Curr. Infect. Dis. Rep., 2002, 4(6), 491-497.
[http://dx.doi.org/10.1007/s11908-002-0034-y] [PMID: 12433323]
[42]
Badrul Islam, M.D. Prevalence of Extended Spectrum β-Lactamases in hospitalized patients and community patients. Bangladesh J Infect Dis., 2018, 5(2), 61-64.
[http://dx.doi.org/10.3329/bjid.v5i2.42152]
[43]
Shah, AA.; Hasan, F.; Ahmed, S.; Hameed, A. Prevalence of extended spectrum β-lactamases in nosocomial and outpatients. Pak. J. Med. Sci., 2003, 19(3), 187-191.
[44]
Hussain, M.; Hasan, F.; Shah, A.A.; Hameed, A.; Jung, M.; Rayamajhi, N.; Cha, S-B.; Yoo, H.S. Prevalence of class A and AmpC β-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn. J. Infect. Dis., 2011, 64(3), 249-252.
[PMID: 21617313]

Rights & Permissions Print Cite
Article Metrics
22
1
© 2024 Bentham Science Publishers | Privacy Policy